{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibptrvw4sivqcbzglopdw7cy5cekfeb7djid7ca5ebppbdvjtdngy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mj7nm5qrfug2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid4hmzr7gu6z2uaskz23eg26wnncjas5iy6nsamtjurqasmqotmpm"
    },
    "mimeType": "image/jpeg",
    "size": 252646
  },
  "path": "/news/2026-04-genetic-variants-people-bloodsugar-response.html",
  "publishedAt": "2026-04-11T06:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators.",
  "title": "Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs"
}